Role of α-Synuclein Regions in Nucleation and Elongation of Amyloid Fiber Assembly

ACS Chem Neurosci. 2020 Mar 18;11(6):872-879. doi: 10.1021/acschemneuro.9b00527. Epub 2020 Mar 4.

Abstract

α-Synuclein is an intrinsically disordered protein whose aggregation in the form of amyloid fibers is directly implicated in Parkinson's disease and other neurological disorders. α-Synuclein is composed of three different regions. The central region (61-95), called NAC, is responsible for protein fibrillation. The N-terminal region (1-61) has some helical propensity and can be divided into H1 (1-31) and H2 (32-61), while the highly acidic C-terminal region (96-140) is completely disordered. It has been postulated that the acidic character of the C-terminus, as well as the interaction between the soluble N- and C- terminal parts, protects the NAC region from fibrillation. In consequence, N- and C-terminal deletions increase α-synuclein fibrillation. Both N- and C-terminal truncations are common in synucleinopathies, but despite their clinical relevance, to date, there are no systematic and exhaustive studies that quantify the effect of these truncations in fiber nucleation and elongation. In this work, we measured both nucleation and fibrillation elongation kinetics in order to study the influence of N- and C-terminal deletions, including the simultaneous deletion of several regions, in α-synuclein fibrillation. We also tested whether the fibrillation prone mutation A53T had an additional effect when combined with truncations. Furthermore, our cross-seeding experiments showed that the deletions studied induce changes in fiber morphology. Our results unravel then the role of the different α-synuclein regions and the A53T mutation in the nucleation and elongation of amyloid fibers.

Keywords: A53T mutant; Parkinson’s disease; amyloid; elongation; nucleation; α-Synuclein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid*
  • Amyloidogenic Proteins
  • Humans
  • Kinetics
  • Mutation
  • Parkinson Disease* / metabolism
  • alpha-Synuclein*

Substances

  • Amyloid
  • Amyloidogenic Proteins
  • alpha-Synuclein